These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22767470)
1. Research on psychedelic substances. Brandt SD; Passie T Drug Test Anal; 2012; 4(7-8):539-42. PubMed ID: 22767470 [No Abstract] [Full Text] [Related]
2. Cannabinoids and hallucinogens for headache. McGeeney BE Headache; 2013 Mar; 53(3):447-58. PubMed ID: 23278122 [TBL] [Abstract][Full Text] [Related]
3. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Palamar JJ; Acosta P Hum Psychopharmacol; 2020 Jan; 35(1):e2719. PubMed ID: 31909513 [TBL] [Abstract][Full Text] [Related]
4. Editor's introduction: psychedelic resurgence--research and therapeutic uses, past and present. Chambers T J Psychoactive Drugs; 2014; 46(1):1-2. PubMed ID: 24830179 [No Abstract] [Full Text] [Related]
5. Patterns of drug use have varied throughout history. Burnap D Nature; 2009 Jan; 457(7229):533. PubMed ID: 19177110 [No Abstract] [Full Text] [Related]
6. Chemistry and Structure-Activity Relationships of Psychedelics. Nichols DE Curr Top Behav Neurosci; 2018; 36():1-43. PubMed ID: 28401524 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity-relationships of certain hallucinogenic substances based on brain levels. Vogel WH; Evans BD Life Sci; 1977 May; 20(10):1629-35. PubMed ID: 69244 [No Abstract] [Full Text] [Related]
8. Structure activity relations of some indolealkylamines in comparison to phenethylamines on motor activity and acquisition of avoidance behavior. Vasko MR; Lutz MP; Domino EF Psychopharmacologia; 1974 Mar; 36(1):49-58. PubMed ID: 4525044 [No Abstract] [Full Text] [Related]
9. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Carhart-Harris RL; Goodwin GM Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617 [TBL] [Abstract][Full Text] [Related]
10. The discovery and development of the triptans, a major therapeutic breakthrough. Humphrey PP Headache; 2008 May; 48(5):685-7. PubMed ID: 18471110 [TBL] [Abstract][Full Text] [Related]
11. An electrophysiological analysis of hallucinogens. Cowen MA; Nishi H; Hammack D Biol Psychiatry; 1973 Dec; 5(3):239-56. PubMed ID: 4708679 [No Abstract] [Full Text] [Related]
12. Progress with several models for the study of the SAR of hallucinogenic agents. Kier LB; Glennon RA NIDA Res Monogr; 1978; (22):159-85. PubMed ID: 101879 [No Abstract] [Full Text] [Related]
13. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats. Sloviter RS; Drust EG; Damiano BP; Connor JD J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720 [No Abstract] [Full Text] [Related]
14. Why psychiatry needs psychedelics and psychedelics need psychiatry. Sessa B J Psychoactive Drugs; 2014; 46(1):57-62. PubMed ID: 24830186 [TBL] [Abstract][Full Text] [Related]
16. Journal of Psychoactive Drugs. A brief history. J Psychoactive Drugs; 2014; 46(1):1 p preceding 1. PubMed ID: 24830178 [No Abstract] [Full Text] [Related]
17. The Role of the Smith DE J Psychoactive Drugs; 2019; 51(2):98-101. PubMed ID: 30890033 [TBL] [Abstract][Full Text] [Related]
18. Hallucinogens and cannabinoids for headache. McGeeney BE Headache; 2012 Oct; 52 Suppl 2():94-7. PubMed ID: 23030539 [TBL] [Abstract][Full Text] [Related]
19. Treatment of alcoholism using psychedelic drugs: a review of the program of research. Mangini M J Psychoactive Drugs; 1998; 30(4):381-418. PubMed ID: 9924844 [TBL] [Abstract][Full Text] [Related]